Eyenovia announces fda acceptance of the mydcombi nda

New york--(business wire)-- #mydriasis--fda accepts eyenovia's nda for mydcombi, a unique fixed combination pupil dilation agent delivered with the optejet. pdufa date is expected 4q 2021.

EYEN Ratings Summary

EYEN Quant Ranking